MENU
TGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TG Therapeutics (TGTX) Earnings Date & Reports

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

TGTX is expected to report earnings to fall 86.94% to 31 cents per share on March 03

TG Therapeutics TGTX Stock Earnings Reports
Q4'25
Est.
$0.32
Q3'25
Beat
by $2.21
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.07
The last earnings report on November 03 showed earnings per share of $2.43, beating the estimate of 21 cents. With 1.64M shares outstanding, the current market capitalization sits at 4.91B.
View a ticker or compare two or three
TGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TGTX showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com